{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T03:27:47Z","timestamp":1781753267954,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-024-04094-5","type":"journal-article","created":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T03:16:58Z","timestamp":1723778218000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Safety and effectiveness of left atrial appendage closure in atrial fibrillation patients with different types of heart failure"],"prefix":"10.1186","volume":"24","author":[{"given":"Liping","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huakang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,16]]},"reference":[{"issue":"1","key":"4094_CR1","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/jce.15759","volume":"34","author":"KA Bizhanov","year":"2023","unstructured":"Bizhanov KA, Abzaliyev KB, Baimbetov AK, et al. Atrial fibrillation: Epidemiology, pathophysiology, and clinical complications (literature review)[J]. J Cardiovasc Electrophysiol. 2023;34(1):153\u201365.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"1","key":"4094_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/14779072.2023.2160319","volume":"21","author":"SE Choi","year":"2023","unstructured":"Choi SE, Sagris D, Hill A, et al. trial fibrillation and stroke[J]. Expert Rev Cardiovasc Ther. 2023;21(1):35\u201356.","journal-title":"Expert Rev Cardiovasc Ther."},{"issue":"2","key":"4094_CR3","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","volume":"140","author":"CT January","year":"2019","unstructured":"January CT, Wann LS, Calkins H, et al. 2019 AHA\/ACC\/HRS Focused Update of the 2014 AHA\/ACC\/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons. Circulation. 2019;140(2):e125\u201351.","journal-title":"Circulation"},{"issue":"4","key":"4094_CR4","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1161\/CIRCULATIONAHA.121.056355","volume":"145","author":"AP Carnicelli","year":"2022","unstructured":"Carnicelli AP, Hong H, Connolly SJ, et al. Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex. Circulation. 2022;145(4):242\u201355.","journal-title":"Circulation"},{"issue":"3","key":"4094_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.7326\/M19-0087","volume":"171","author":"JT Ha","year":"2019","unstructured":"Ha JT, Neuen BL, Cheng LP, et al. Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease: A Systematic Review and Meta-analysis. Ann Intern Med. 2019;171(3):181\u20139.","journal-title":"Ann Intern Med"},{"issue":"10","key":"4094_CR6","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365(10):883\u201391. https:\/\/doi.org\/10.1056\/NEJMoa1009638.","journal-title":"N Engl J Med"},{"issue":"22","key":"4094_CR7","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","volume":"369","author":"RP Giugliano","year":"2013","unstructured":"Giugliano RP, Ruff CT, Braunwald E, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369(22):2093\u2013104.","journal-title":"N Engl J Med"},{"issue":"2 Suppl","key":"4094_CR8","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/01.STR.0000250166.06949.95","volume":"38","author":"O Onalan","year":"2007","unstructured":"Onalan O, Crystal E. Left atrial appendage exclusion for stroke prevention in patients with nonrheumatic atrial fibrillation. Stroke. 2007;38(2 Suppl):624\u201330.","journal-title":"Stroke"},{"issue":"24","key":"4094_CR9","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","volume":"70","author":"VY Reddy","year":"2017","unstructured":"Reddy VY, Doshi SK, Kar S, et al. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials. J Am Coll Cardiol. 2017;70(24):2964\u201375.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"4094_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2021.10.023","volume":"79","author":"P Osmancik","year":"2022","unstructured":"Osmancik P, Herman D, Neuzil P, et al. 4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation. J Am Coll Cardiol. 2022;79(1):1\u201314.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"4094_CR11","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jchf.2019.03.005","volume":"7","author":"MA Carlisle","year":"2019","unstructured":"Carlisle MA, Fudim M, DeVore AD, et al. Heart Failure and Atrial Fibrillation, Like Fire and Fury. JACC Heart Fail. 2019;7(6):447\u201356.","journal-title":"JACC Heart Fail"},{"issue":"5","key":"4094_CR12","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.hrthm.2017.01.042","volume":"14","author":"A Coisne","year":"2017","unstructured":"Coisne A, Pilato R, Brigadeau F, et al. Percutaneous left atrial appendage closure improves left atrial mechanical function through Frank-Starling mechanism. Heart Rhythm. 2017;14(5):710\u20136.","journal-title":"Heart Rhythm"},{"issue":"7","key":"4094_CR13","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1253\/circj.CJ-21-0642","volume":"86","author":"DY Kim","year":"2022","unstructured":"Kim DY, Kim MJ, Seo J, et al. Predictors of Subsequent Heart Failure After Left Atrial Appendage Closure. Circ J. 2022;86(7):1129\u201336.","journal-title":"Circ J"},{"issue":"18","key":"4094_CR14","first-page":"e876","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e876\u201394.","journal-title":"Circulation"},{"issue":"1","key":"4094_CR15","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1186\/s12872-020-01708-6","volume":"20","author":"ZH Zhang","year":"2020","unstructured":"Zhang ZH, Yao Q, Huang HY, et al. \u201cOne-stop shop\u201d: safety and efficacy of combining atrial septal defect occlusion and left atrial appendage closure for patients with atrial septal defect and atrial fibrillation. BMC Cardiovasc Disord. 2020;20(1):444.","journal-title":"BMC Cardiovasc Disord"},{"issue":"12","key":"4094_CR16","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.recesp.2016.10.014","volume":"69","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, et al. ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. Rev Esp Cardiol (Engl Ed). 2016;69(12):1167 English, Spanish.","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"9989","key":"4094_CR17","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S0140-6736(14)61774-8","volume":"386","author":"RB Schnabel","year":"2015","unstructured":"Schnabel RB, Yin X, Gona P, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet. 2015;386(9989):154\u201362.","journal-title":"Lancet"},{"issue":"21","key":"4094_CR18","doi-asserted-by":"publisher","first-page":"5101","DOI":"10.3390\/jcm10215101","volume":"10","author":"Y Cottin","year":"2021","unstructured":"Cottin Y, Maalem Ben Messaoud B. Temporal Relationship between Atrial Fibrillation and Heart Failure Development Analysis from a Nationwide Database. J Clin Med. 2021;10(21):5101.","journal-title":"J Clin Med"},{"issue":"265","key":"4094_CR19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ijcard.2018.04.093","volume":"15","author":"JM Siller-Matula","year":"2018","unstructured":"Siller-Matula JM, Pecen L, Patti G, et al. Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy. Int J Cardiol. 2018;15(265):141\u20137.","journal-title":"Int J Cardiol"},{"issue":"1","key":"4094_CR20","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/ehf2.14130","volume":"10","author":"M Budnik","year":"2023","unstructured":"Budnik M, Gawa\u0142ko M, Lodzi\u0144ski P, et al. Heart failure in patients with atrial fibrillation: Insights from Polish part of the EORP-AF general long-term registry. ESC Heart Fail. 2023;10(1):637\u201349. https:\/\/doi.org\/10.1002\/ehf2.14130.","journal-title":"ESC Heart Fail"},{"issue":"203","key":"4094_CR21","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.ijcard.2015.10.220","volume":"15","author":"D Kotecha","year":"2016","unstructured":"Kotecha D, Chudasama R, Lane DA, et al. Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: A systematic review and meta-analysis of death and adverse outcomes. Int J Cardiol. 2016;15(203):660\u20136.","journal-title":"Int J Cardiol"},{"issue":"1","key":"4094_CR22","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/ehf2.13698","volume":"9","author":"M Saad","year":"2022","unstructured":"Saad M, Osman M, Hasan-Ali H, et al. Atrial appendage closure in patients with heart failure and atrial fibrillation: industry-independent single-centre study. ESC Heart Fail. 2022;9(1):648\u201355.","journal-title":"ESC Heart Fail"},{"issue":"11","key":"4094_CR23","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s00392-020-01627-8","volume":"109","author":"C Fastner","year":"2020","unstructured":"Fastner C, Brachmann J, Lewalter T, et al. Left atrial appendage closure in patients with a reduced left ventricular ejection fraction: results from the multicenter German LAARGE registry. Clin Res Cardiol. 2020;109(11):1333\u201341.","journal-title":"Clin Res Cardiol"},{"issue":"9","key":"4094_CR24","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1161\/CIRCULATIONAHA.118.035090","volume":"138","author":"SR Dukkipati","year":"2018","unstructured":"Dukkipati SR, Kar S, Holmes DR, et al. Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes. Circulation. 2018;138(9):874\u201385.","journal-title":"Circulation"},{"issue":"4","key":"4094_CR25","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.118.006841","volume":"12","author":"LV Boersma","year":"2019","unstructured":"Boersma LV, Ince H, Kische S, et al. Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage. Circ Arrhythm Electrophysiol. 2019;12(4): e006841.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"14","key":"4094_CR26","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.jacc.2018.01.076","volume":"71","author":"L Fauchier","year":"2018","unstructured":"Fauchier L, Cinaud A, Brigadeau F, et al. Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation. J Am Coll Cardiol. 2018;71(14):1528\u201336.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"4094_CR27","doi-asserted-by":"publisher","first-page":"E111","DOI":"10.1002\/ccd.26903","volume":"90","author":"M Lempereur","year":"2017","unstructured":"Lempereur M, Aminian A, Freixa X, et al. Device-associated thrombus formation after left atrial appendage occlusion: A systematic review of events reported with the Watchman, the Amplatzer Cardiac Plug and the Amulet. Catheter Cardiovasc Interv. 2017;90(5):E111\u201321.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"6","key":"4094_CR28","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.1002\/ehf2.14105","volume":"9","author":"MT Wybraniec","year":"2022","unstructured":"Wybraniec MT, Mizia-Szubryt M, Cicho\u0144 M, et al. Heart failure and the risk of left atrial thrombus formation in patients with atrial fibrillation or atrial flutter. ESC Heart Fail. 2022;9(6):4064\u201376.","journal-title":"ESC Heart Fail"},{"issue":"12","key":"4094_CR29","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/j.jacep.2018.09.007","volume":"4","author":"M Alkhouli","year":"2018","unstructured":"Alkhouli M, Busu T, Shah K, et al. Incidence and Clinical Impact of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion: A Meta-Analysis. JACC Clin Electrophysiol. 2018;4(12):1629\u201337. https:\/\/doi.org\/10.1016\/j.jacep.2018.09.007.","journal-title":"JACC Clin Electrophysiol"},{"issue":"7","key":"4094_CR30","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.hlc.2017.07.001","volume":"27","author":"B Luani","year":"2018","unstructured":"Luani B, Rauwolf T, Groscheck T, et al. Serial Assessment of Natriuretic Peptides in Patients Undergoing Interventional Closure of the Left Atrial Appendage. Heart Lung Circ. 2018;27(7):828\u201334.","journal-title":"Heart Lung Circ"},{"issue":"11","key":"4094_CR31","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.jcin.2018.10.021","volume":"12","author":"G Patti","year":"2019","unstructured":"Patti G, Rapacciuolo A, Segreti A, et al. Percutaneous Left Atrial Appendage Closure: Acute Effects on Left Atrial Pressure in Humans. JACC Cardiovasc Interv. 2019;12(11):1089\u201391.","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"4094_CR32","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/clc.23824","volume":"45","author":"MR Mostafa","year":"2022","unstructured":"Mostafa MR, Magdi M, Al-Abdouh A, et al. A systematic review and meta-analysis of the impact of the left atrial appendage closure on left atrial function. Clin Cardiol. 2022;45(6):614\u201321.","journal-title":"Clin Cardiol"},{"issue":"10","key":"4094_CR33","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1111\/echo.14087","volume":"35","author":"D Kitkungvan","year":"2018","unstructured":"Kitkungvan D, Yusuf SW, Moudgil R, et al. Echocardiographic measures associated with the presence of left ventricular thrombus in patients with chemotherapy-related cardiac dysfunction. Echocardiography. 2018;35(10):1512\u20138.","journal-title":"Echocardiography"},{"issue":"6","key":"4094_CR34","doi-asserted-by":"publisher","first-page":"520","DOI":"10.21037\/atm-20-7839","volume":"9","author":"JB Cruz Rodriguez","year":"2021","unstructured":"Cruz Rodriguez JB, Okajima K, Greenberg BH. Management of left ventricular thrombus: a narrative review. Ann Transl Med. 2021;9(6):520.","journal-title":"Ann Transl Med"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-04094-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-024-04094-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-04094-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T03:17:22Z","timestamp":1723778242000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-024-04094-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,16]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4094"],"URL":"https:\/\/doi.org\/10.1186\/s12872-024-04094-5","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,16]]},"assertion":[{"value":"29 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients provided written informed consent to participate in this study, and the Ethics Committee of the First Affiliated Hospital of Third Military Medical University approved the study protocol.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to publication, and there are no permissions needed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"430"}}